Cefminox

Cefminox is a semi-synthetic, second-generation cephalosporin antibiotic. It is used in the treatment of bacterial infections. It is characterized by its broad-spectrum activity, demonstrating efficacy against a range of Gram-positive and Gram-negative bacteria. Cefminox is primarily administered intravenously or intramuscularly due to poor oral absorption. Its mechanism of action involves the inhibition of bacterial cell wall synthesis, leading to bacterial cell death. Common clinical uses include the treatment of respiratory tract infections, urinary tract infections, skin and soft tissue infections, and intra-abdominal infections. Potential side effects, as with other cephalosporins, can include hypersensitivity reactions, gastrointestinal disturbances, and, rarely, hematological abnormalities. It is typically reserved for situations where other antibiotics are ineffective or inappropriate due to resistance patterns. Cefminox is marketed under various brand names and is subject to local regulations regarding its prescription and usage.